Recurrent Molar Pregnancy: An Obstetric Dilemma?

ABSTRACT Approximately 1% of women with a molar pregnancy may have a recurrence. Chemotherapy is not indicated for recurrent molar pregnancies. An adequate interconception interval is important to ensure that the serum beta-human chorionic gonadotropin (β-hCG) from a new pregnancy does not interfere with the follow-up of the molar pregnancy that is done to detect persistent disease. We discuss the case of a nulliparous woman who had four molar pregnancies and her future reproductive options. How to cite this article Marakani LR, Gundabattula SR. Recurrent Molar Pregnancy: An Obstetric Dilemma? Int J Infertility Fetal Med 2012;3(2):63-64.

Download Full-text

Beta-human chorionic gonadotropin levels as early predictor for progression to Gestational Trophoblastic Neoplasia after molar pregnancy evacuation at a Philippine tertiary hospital

Philippine Journal of Obstetrics and Gynecology ◽

10.4103/pjog.pjog_24_21 ◽

2021 ◽

Vol 45 (4) ◽

pp. 153

Author(s):

MayDelight G. Galingan ◽

MaStephanie Fay S. Cagayan

Keyword(s):

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Tertiary Hospital ◽

Molar Pregnancy ◽

Gestational Trophoblastic Neoplasia ◽

Beta Human Chorionic Gonadotropin ◽

Early Predictor

Download Full-text

Single Beta-Human Chorionic Gonadotropin (β-hCG) Value as a Predictor of Pregnancy Outcome for In Vitro Fertilization (IVF) Cycles

Fertility and Sterility ◽

10.1016/j.fertnstert.2005.07.755 ◽

2005 ◽

Vol 84 ◽

pp. S289-S290

Author(s):

J. Kuo ◽

N. Patel ◽

S. Sarajari ◽

T.C. Wu ◽

A.H. Decherney

Keyword(s):

In Vitro Fertilization ◽

Pregnancy Outcome ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Vitro Fertilization ◽

Beta Human Chorionic Gonadotropin ◽

Β Hcg

Download Full-text

Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes

Journal of Obstetrics and Gynaecology ◽

10.3109/01443615.2015.1036400 ◽

2015 ◽

Vol 36 (2) ◽

pp. 178-182 ◽

Cited By ~ 21

Author(s):

P. Sirikunalai ◽

C. Wanapirak ◽

S. Sirichotiyakul ◽

F. Tongprasert ◽

K. Srisupundit ◽

...

Keyword(s):

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Pregnancy Outcomes ◽

Maternal Serum ◽

Adverse Pregnancy Outcomes ◽

Serum Free ◽

Beta Human Chorionic Gonadotropin ◽

Adverse Pregnancy ◽

Β Hcg

Download Full-text

Analysis of 309 Cases after Hydatidiform Mole: Different Follow-Up Program According to Biologic Behavior

Tumori Journal ◽

10.1177/030089168807400116 ◽

1988 ◽

Vol 74 (1) ◽

pp. 93-96 ◽

Cited By ~ 6

Author(s):

Giorgio Bolis ◽

Carlo Belloni ◽

Cristina Bonazzi ◽

Giorgia Mangili ◽

Mauro Presti ◽

...

Keyword(s):

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Selection Criteria ◽

Hydatidiform Mole ◽

Spontaneous Remission ◽

Obstetrics And Gynecology ◽

Surveillance Program ◽

Beta Human Chorionic Gonadotropin ◽

Trophoblastic Tumors

Between 1976 and 1985, at the Obstetrics and Gynecology Department of Milan University, a total of 309 cases of hydatidiform mole, 223 complete moles and 86 partial moles, were monitored with the assay of beta-human chorionic gonadotropin, following a postmolar biochemical surveillance program. Spontaneous remission of the disease occurred in 287 (92.9%) patients. Marker levels were undetectable in 80.4 % of cases within 60 days after evacuation of the mole and in 19.6% between 61 and 140 days. There were 22 (7.1%) patients diagnosed as having gestational trophoblastic tumors (GTT) and treated with chemotherapy: 20 were complete moles and 2 partial moles. Considering these data, the authors suggest different follow-up times for partial and complete moles and confirm the necessity of selection criteria in a diagnosis of GTT.

Download Full-text